Compare · HSAQ vs MDLN
HSAQ vs MDLN
Side-by-side comparison of Health Sciences Acquisitions Corporation 2 (HSAQ) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HSAQ and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.40B, about 220.2x HSAQ ($201.6M).
- MDLN has hit the wire 20 times in the past 4 weeks while HSAQ has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 0 for HSAQ).
- Company
- Health Sciences Acquisitions Corporation 2
- Medline Inc.
- Price
- $13.31+25.98%
- $33.80+0.58%
- Market cap
- $201.6M
- $44.40B
- 1M return
- -
- -19.55%
- 1Y return
- -
- -17.07%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2025
- News (4w)
- 0
- 20
- Recent ratings
- 0
- 25
HSAQ
Health Sciences Acquisitions Corporation 2
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest HSAQ
- SEC Form 5 filed by Medtronic Plc
- SEC Form SC 13G/A filed by Health Sciences Acquisitions Corporation 2 (Amendment)
- SEC Form SC 13G/A filed by Health Sciences Acquisitions Corporation 2 (Amendment)
- SEC Form SC 13G filed by Health Sciences Acquisitions Corporation 2
- Health Sciences Acquisitions Corporation 2 filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Health Sciences Acquisitions Corporation 2 filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-Q filed by Health Sciences Acquisitions Corporation 2
- Health Sciences Acquisitions Corporation 2 filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form S-1 filed by Health Sciences Acquisitions Corporation 2
- New insider Papandreou George claimed ownership of 20,000 shares (SEC Form 3)
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)